Decoy Therapeutics Advances AI Antiviral Pipeline Fast
CAMBRIDGE, Mass. & HOUSTON, April 9, 2026 Decoy Therapeutics, Inc. is rapidly gaining momentum as it enters a highly...
AI drug discovery
Advertisement
Dyno AI Capsid Licensed by Astellas for Gene Therapy
WATERTOWN, Mass., April 8, 2026 Dyno Therapeutics, Inc. has announced that Astellas Pharma has exercised its option to license...
Merck Partners Infinimmune in $838M Antibody Discovery Deal
RAHWAY, N.J., USA — March 31, 2026 Merck & Co. has entered into a strategic antibody discovery collaboration with...
Insilico, Lilly Sign $2.75B AI Drug Discovery Deal
Hong Kong | March 30, 2026 Strategic AI Collaboration to Accelerate Drug Discovery Insilico Medicine has announced a major...
AI Drug Discovery Deal Expands CNS Pipeline Value
Hong Kong | March 30, 2026 AI Collaboration Accelerates CNS Drug Discovery Insilico Medicine and Tenacia Biotechnology have announced...
Advertisements
AI Transforms Pharma R&D and Manufacturing Models
London, United Kingdom | March 23, 2026 The pharmaceutical industry is undergoing a profound transformation as artificial intelligence (AI),...
Manifold Bio Demonstrates AI Protein Design Breakthrough
Boston, Massachusetts, March 16, 2026 Manifold Bio, a platform therapeutics company focused on AI-driven drug discovery, announced breakthrough results...
Roche Launches NVIDIA AI Factory for Drug Discovery
Basel, March 16, 2026 Roche announced the launch of a large-scale NVIDIA-powered AI factory, marking a major advancement in...
PRISM BioLab and Receptor.AI Partner for AI Drug Discovery
TOKYO, Japan & CAMBRIDGE, Mass., March 13, 2026 PRISM BioLab Co., Ltd. and Receptor.AI Inc. have announced a strategic...
BioXcel Therapeutics Secures $8M Registered Direct Offering
NEW HAVEN, Connecticut — March 10, 2026 Biotechnology company BioXcel Therapeutics Inc. has announced a registered direct offering expected...
Advertisement
